Skip to content

Clinical trials

Phase 2/3 Anemia, Sickle Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 2/3 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20081
20101
20122
20171
20182
20191
20201
20223
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status5
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
Pfizer2
Agios Pharmaceuticals, Inc.1
Ain Shams University1
Al-Neelain University1
Beni-Suef University1
Great Ormond Street Hospital for Children NHS Foundation Trust1
Indiana University1
London School of Hygiene and Tropical Medicine1
Makerere University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell17
Vaso-Occlusive Crises2
beta-Thalassemia2
Acute Chest Syndrome1
Acute Lung Injury1
Anemia, Diamond-Blackfan1
Hematologic Diseases1
Hemoglobinopathies1
Shwachman-Diamond Syndrome1
Sleep Apnea Syndromes1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.